AR-13533

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAR-13533
Drug Alias NameAR-13533
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitorsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterRho-associated kinases
Therapy Area/IndicationsOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAerie Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAerie Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A